China

Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
Fierce Pharma
FDA
patents
generics
copycat drugs
China
Flag link:
June 14 P&P Quick Takes: Washington state approved for subscription HCV model; plus Merck and IBM, BGI, and more
June 14 P&P Quick Takes: Washington state approved for subscription HCV model; plus Merck and IBM, BGI, and more
BioCentury
Washington
Netflix model
hepatitis C
BGI Genomics
China
distribution
Flag link:
Tessa Therapeutics Forges $120 Million Joint Venture to Develop Cell Therapies in China
Tessa Therapeutics Forges $120 Million Joint Venture to Develop Cell Therapies in China
BioSpace
Tessa Therapeutics
cell therapy
cancer
China-Singapore Guangzhou Knowledge City
China
Flag link:
Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial probe
Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial probe
Fierce Pharma
China
Sanofi
Eli Lilly
Bristol-Myers Squibb
Flag link:
Fast moving Chinese regulators wave third homegrown PD-1 to market
Fast moving Chinese regulators wave third homegrown PD-1 to market
Endpoints
China
Jiangsu Hengrui Medicine
PD-1 inhibitors
Flag link:
China's driving sales growth ahead of the U.S. for Big Pharma. But can it last?
China's driving sales growth ahead of the U.S. for Big Pharma. But can it last?
Fierce Pharma
China
Big Pharma
Flag link:
US Crackdown On Foreign Biotech Investment Makes Us Poorer, Not Safer
US Crackdown On Foreign Biotech Investment Makes Us Poorer, Not Safer
Forbes
biotech
international investment
China
Flag link:
GlaxoSmithKline's booming Shingrix, after VIP invite, wins nod to tackle China
GlaxoSmithKline's booming Shingrix, after VIP invite, wins nod to tackle China
Fierce Pharma
GSK
vaccines
Shingrix
shingles
China
Flag link:
[video]Top vaccine makers Merck and Pfizer target China and older adults next
[video]Top vaccine makers Merck and Pfizer target China and older adults next
Yahoo/CNBC
vaccines
Merck
Pfizer
Sanofi Pasteur
GSK
China
Flag link:
With potential launches nearing, Zai taps investors for $200M
With potential launches nearing, Zai taps investors for $200M
BioCentury
Zai Lab
China
drug launches
Flag link:
Soriot sees progress in U.S.-China IP debate
Soriot sees progress in U.S.-China IP debate
BioCentury
China
AstraZeneca
Pascal Soriot
intellectual property
Flag link:
Lilly to sell legacy antibiotics, Ceclor and Vancocin, to China-based partner in $375M deal
Lilly to sell legacy antibiotics, Ceclor and Vancocin, to China-based partner in $375M deal
Endpoints
Eli Lilly
China
antibiotics
Ceclor
Vancocin
Eddingpharm
Flag link:
This Chinese pharma filed for an IPO last September. Seven months and a $283M investment later, they are back at the HKEX
This Chinese pharma filed for an IPO last September. Seven months and a $283M investment later, they are back at the HKEX
Endpoints
Hansoh Pharmaceutical
China
IPOs
Hong Kong
Flag link:
FDA's Pazdur encourages Chinese companies to bring low-cost PD-1 drugs to U.S. market
FDA's Pazdur encourages Chinese companies to bring low-cost PD-1 drugs to U.S. market
BioCentury
Richard Pazdur
FDA
China
anti-PD-L1
Flag link:
U.S., China key to GSK's consumer venture with Pfizer
U.S., China key to GSK's consumer venture with Pfizer
Yahoo/Reuters
China
GSK
Pfizer
consumer healthcare
Flag link:
Keytruda nabs key lung cancer nod in China. But are blockbuster sales really attainable?
Keytruda nabs key lung cancer nod in China. But are blockbuster sales really attainable?
Fierce Pharma
Merck
Keytruda
China
advanced non-squamous non-small cell lung cancer
Flag link:
China lists 30 more overseas drugs eligible for Priority Review
China lists 30 more overseas drugs eligible for Priority Review
BioCentury
China
drug approvals
Flag link:
AstraZeneca to help build new life science research cluster in China
AstraZeneca to help build new life science research cluster in China
Fierce Biotech
AstraZeneca
China
R&D
Flag link:
Medtronic launches Shanghai-based medtech incubator
Medtronic launches Shanghai-based medtech incubator
Mass Device
Medtronic
devices
Shanghai
China
device company incubators
Flag link:
Novartis launches COPD inhalers in China
Novartis launches COPD inhalers in China
Drug Delivery Business News
Novartis
COPD
China
Ultibro Breezhaler
Seebri Breezhaler
devices
Flag link:

Pages